TY  - GEN
AU  - Myers,L W
TI  - Immunologic therapy for secondary and primary progressive multiple sclerosis
SN  - 1528-4042
PY  - 2002///0513
KW  - Adjuvants, Immunologic
KW  - therapeutic use
KW  - Adrenal Cortex Hormones
KW  - Adult
KW  - Anti-Inflammatory Agents
KW  - Antilymphocyte Serum
KW  - Autoimmune Diseases
KW  - classification
KW  - Cladribine
KW  - Clinical Trials as Topic
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Disease Progression
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Forecasting
KW  - Glatiramer Acetate
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Immunoglobulins, Intravenous
KW  - Immunosuppressive Agents
KW  - Interferon beta-1a
KW  - Interferon beta-1b
KW  - Interferon-beta
KW  - Middle Aged
KW  - Mitoxantrone
KW  - Multicenter Studies as Topic
KW  - Multiple Sclerosis
KW  - Peptides
KW  - Plasma Exchange
KW  - Randomized Controlled Trials as Topic
KW  - Steroids
KW  - T-Lymphocytes
KW  - immunology
KW  - Treatment Outcome
KW  - Vaccination
N1  - Publication Type: Comparative Study; Journal Article; Review
UR  - https://doi.org/10.1007/s11910-001-0032-8
ER  -